We are live on ! Find out more
OPU

Omni Partners US Portfolio holdings

AUM $1.95B
This Fund
S&P 500
This Quarter Est. Return
+7.21%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.95B
AUM Growth
-$319M
Cap. Flow
-$362M
Cap. Flow %
-18.57%
Top 10 Hldgs %
50.07%
Holding
304
New
78
Increased
103
Reduced
62
Closed
60

Sector Composition

Rank Sector Weight
1 Financials 18.3%
2 Technology 15.69%
3 Industrials 13.34%
4 Communication Services 11.51%
5 Healthcare 10.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PIII icon
51
P3 Health Partners
PIII
$33.5M
$6.54M 0.34%
13,259
+9,141
+222% +$4.5M
SST icon
52
System1
SST
$14.3M
$6.43M 0.33%
+64,853
New +$6.42M
AGAC
53
DELISTED
African Gold Acquisition Corp
AGAC
$6.35M 0.33%
653,618
+14,468
+2% +$140K
KCAC
54
DELISTED
Kensington Capital Acquisition Corp. II
KCAC
$6.32M 0.32%
763,115
+31,998
+4% +$316K
GRNA
55
DELISTED
GreenLight Biosciences Holdings, PBC Common Stock
GRNA
$6.21M 0.32%
+628,312
New +$6.16M
EUSG
56
DELISTED
European Sustainable Growth Acquisition Corp. Class A Ordinary Shares
EUSG
$6.07M 0.31%
+612,640
New +$6.01M
MDH
57
DELISTED
MDH Acquisition Corp.
MDH
$5.83M 0.3%
592,017
+484,780
+452% +$4.74M
HCAR
58
DELISTED
Healthcare Services Acquisition Corporation Class A Common Stock
HCAR
$5.58M 0.29%
572,350
-64,618
-10% -$626K
FMIV
59
DELISTED
Forum Merger IV Corporation Class A Common stock
FMIV
$5.53M 0.28%
566,982
+23,364
+4% +$227K
LGV
60
DELISTED
Longview Acquisition Corp. II
LGV
$5.5M 0.28%
+556,570
New +$5.49M
GGPI
61
DELISTED
Gores Guggenheim, Inc. Class A Common Stock
GGPI
$5.48M 0.28%
535,943
-101,632
-16% -$1.01M
ASAX
62
DELISTED
Astrea Acquisition Corp. Class A Common Stock
ASAX
$5.29M 0.27%
531,297
+354,954
+201% +$3.47M
PACX
63
DELISTED
Pioneer Merger Corp. Class A Ordinary Share
PACX
$5.26M 0.27%
529,952
+417,343
+371% +$4.13M
SOND
64
DELISTED
Sonder
SOND
$5.21M 0.27%
26,368
+537
+2% +$106K
XPOA
65
DELISTED
DPCM Capital, Inc.
XPOA
$5.18M 0.27%
530,612
+271,707
+105% +$2.66M
SLCR
66
DELISTED
Silver Crest Acquisition Corporation Class A Ordinary Share
SLCR
$5.17M 0.27%
526,389
+296,410
+129% +$2.89M
BZFD icon
67
BuzzFeed
BZFD
$107M
$5.16M 0.26%
130,109
+95,301
+274% +$3.77M
HCCC
68
DELISTED
Healthcare Capital Corp. Class A common stock
HCCC
$5.15M 0.26%
522,614
+334,019
+177% +$3.28M
WARR
69
DELISTED
Warrior Technologies Acquisition Company
WARR
$5.13M 0.26%
522,538
+4,916
+0.9% +$47.9K
MDAI icon
70
Spectral AI
MDAI
$53.5M
$5.12M 0.26%
527,687
+8,486
+2% +$82.2K
AMPS
71
DELISTED
Altus Power
AMPS
$5.12M 0.26%
515,680
+336,709
+188% +$3.34M
DSAQ.U
72
DELISTED
Direct Selling Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of redeemable warrant
DSAQ.U
$5.11M 0.26%
+506,960
New +$5.11M
PIAI
73
DELISTED
Prime Impact Acquisition I
PIAI
$5.09M 0.26%
518,074
+20,854
+4% +$204K
XLRN
74
DELISTED
Acceleron Pharma
XLRN
$5.08M 0.26%
+29,500
New +$3.86M
BTNB
75
DELISTED
Bridgetown 2 Holdings Limited Class A Ordinary Shares
BTNB
$5.06M 0.26%
+510,454
New +$5.09M

Similar funds

Omni Partners US's Q3 2021 Portfolio in Review

As of Q3 2021, Omni Partners US held 304 positions worth $1.95B, down 14% from $2.27B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Omni Partners US withdrew a net $362M in Q3 2021, closing 60 positions and reducing 62 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $326M position sold in full.

By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 17% a quarter earlier, followed by Technology and Industrials.

Against the trend, Omni Partners US opened a new position in Covanta Holding Corporation worth $56.8M.

  • Omni Partners US's largest Q3 2021 buy was Covanta Holding Corporation: 2,822,693 shares worth $56.8M.
  • Omni Partners US added most to Kansas City Southern in Q3 2021, an estimated $127M increase.
  • Omni Partners US's biggest Q3 2021 reduction was Change Healthcare Inc. Common Stock, cutting an estimated $37.2M.
  • Omni Partners US fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $326M.
  • Omni Partners US's ten largest holdings make up 50% of its $1.95B portfolio in Q3 2021.
  • Omni Partners US opened 78 new positions and closed 60 in Q3 2021.
  • Omni Partners US's portfolio value fell 14% quarter-over-quarter to $1.95B.

Based on Omni Partners US's 13F filing for Q3 2021, filed 15 Nov 2021.